Paper41884792
Symptom relief and cytokine modulation by clarithromycin in mild COVID-19 pneumonia: an exploratory, multicenter, randomized-controlled open-label trial (CAME-COVID study).
Yamamoto K and 25 others. Ther Adv Infect Dis, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Symptom relief and cytokine modulation by clarithromycin in mild COVID-19 pneumonia: an exploratory, multicenter, randomized-controlled open-label trial (CAME-COVID study). Papers, record 41884792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41884792
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Symptom relief and cytokine modulation by clarithromycin in mild COVID-19 pneumonia: an exploratory, multicenter, randomized-controlled open-label trial (CAME-COVID study).
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37751595 | Long-Term Safety Profiles of Macrolides and Tetracyclines: A Systematic Review and Meta-Analysis. | J Clin Pharmacol | 2024 | https://conductscience.org/library/papers/37751595 | PubMed |
| 2 | 32678530 | Dexamethasone in Hospitalized Patients with Covid-19. | N Engl J Med | 2021 | https://conductscience.org/library/papers/32678530 | PubMed |
| 3 | 36899952 | Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics. | Cells | 2023 | https://conductscience.org/library/papers/36899952 | PubMed |
| 4 | 38058790 | Post-COVID-19 pulmonary fibrosis: An ongoing concern. | Ann Thorac Med | 2023 | https://conductscience.org/library/papers/38058790 | PubMed |
| 5 | 37023433 | Outpatient treatment of COVID-19: an experience with 552 cases in Mexico. | J Infect Dev Ctries | 2023 | https://conductscience.org/library/papers/37023433 | PubMed |
| 6 | 39094763 | Impact of anti-fibrotic medications on post-COVID-19 pulmonary fibrosis: A systematic review and meta-analysis. | Int J Infect Dis | 2024 | https://conductscience.org/library/papers/39094763 | PubMed |
| 7 | 35223745 | Targeting TNF-α for COVID-19: Recent Advanced and Controversies. | Front Public Health | 2022 | https://conductscience.org/library/papers/35223745 | PubMed |
| 8 | 35289561 | Antibiotics for the Treatment of COVID-19. | Am Fam Physician | 2022 | https://conductscience.org/library/papers/35289561 | PubMed |
| 9 | 34643720 | Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. | JAMA Netw Open | 2021 | https://conductscience.org/library/papers/34643720 | PubMed |
| 10 | 37185637 | Fatigue outcomes following COVID-19: a systematic review and meta-analysis. | BMJ Open | 2023 | https://conductscience.org/library/papers/37185637 | PubMed |
| 11 | 38184008 | Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial. | Lancet Respir Med | 2024 | https://conductscience.org/library/papers/38184008 | PubMed |
| 12 | 37012080 | ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. | Eur Respir J | 2023 | https://conductscience.org/library/papers/37012080 | PubMed |
| 13 | 35008594 | COVID-19: Immunohistochemical Analysis of TGF-β Signaling Pathways in Pulmonary Fibrosis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/35008594 | PubMed |
| 14 | 34363189 | Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial. | Infect Dis Ther | 2021 | https://conductscience.org/library/papers/34363189 | PubMed |
| 15 | 36477182 | Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study. | Clin Infect Dis | 2023 | https://conductscience.org/library/papers/36477182 | PubMed |
| 16 | 24585130 | Antibiotics for acute bronchitis. | Cochrane Database Syst Rev | 2014 | https://conductscience.org/library/papers/24585130 | PubMed |
| 17 | 34249367 | Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients. | New Microbes New Infect | 2021 | https://conductscience.org/library/papers/34249367 | PubMed |
| 18 | 32866645 | Interferon gamma, TGF-β1 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients. | Clin Immunol | 2020 | https://conductscience.org/library/papers/32866645 | PubMed |
| 19 | 39903535 | A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19. | JCI Insight | 2025 | https://conductscience.org/library/papers/39903535 | PubMed |
| 20 | 35245942 | Molnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019 Antiviral Drugs. | Clin Infect Dis | 2023 | https://conductscience.org/library/papers/35245942 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CSF3 | 1440 | PubTator's text mining | https://conductscience.org/library/genes/1440 | NCBI Gene |
| CXCL8 | 3576 | PubTator's text mining | https://conductscience.org/library/genes/3576 | NCBI Gene |
| FLT3LG | 2323 | PubTator's text mining | https://conductscience.org/library/genes/2323 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL15 | 3600 | PubTator's text mining | https://conductscience.org/library/genes/3600 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41884792
GET https://conductscience.org/api/papers/v1/41884792/authors?page=2